Comparison of therapeutic effects between Limaprost alfadex and Gabapentin in cervical myelopathy patient: Randomized controlled trial
- Conditions
- Cervical spondylosis myelopathyCSMGabapentinLimaprost alfadex
- Registration Number
- TCTR20230603001
- Lead Sponsor
- Rajavithi hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
1. 20-80 years old
2. Patients who meet the diagnostic criteria in the following topics
a. Symptom : Neck pain or aching pain down the arm or have numbness Weakness in arms, hands, abnormal gait
b. physical examination : Intrinsic muscle weakness , Finger escape sign + , Grip and release + , lhermitte test +
c. An MRI or CT scan showed narrowing of the spinal canal in the neck. together with spinal cord compression
d. The diagnosis was confirmed by an Orthopedic spine surgeon.
The diagnosis relies on a, b and d together, with or without c.
3. Cooperate consent to participate in the research project
1. History of allergy to gabapentin or Pregabalin
2. History of allergies to NSAIDs, Opioids
3. Peripheral nerve entrapment and other pathology such as Tandem stenosis.
4. Take anti-platelet drugs (ASA), anticoagulant drugs
5. Received NSAID and Gabapentin treatment within 1 week prior to study participation.
6. History of end-stage chronic kidney disease
7. History of heart failure, ischemic heart disease
8. History of cirrhosis
9. History of peptic ulcer disease
10. History of all types of cancer
11. Persons diagnosed with cervical spondylosis with severe symptoms requiring surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain score 0 4 8 weeks after treatment Visual analog scale
- Secondary Outcome Measures
Name Time Method Quality of life before - after treatment SF-36,Motor power , Sensory , Provocation test Before - After treatment Physical examination,Adverse effect In researching time Patient feed back